Table 4 Comparison of the covariates after propensity score matching
Variables | Midazolam n = 140 | Non-midazolam n = 192 | p value |
|---|---|---|---|
Age, years | 67.0 ± 1.0 | 66.6 ± 0.9 | 0.761 |
Male, n(%) | 96(68.5) | 134(69.7) | 0.182 |
Hypertension, n(%) | 24(17.1) | 25(13.0) | 0.296 |
Scr, mg/dl | 1.5 ± 0.1 | 1.3 ± 0.1 | 0.209 |
MI | Â | Â | 0.578 |
 NSTEMI, n(%) | 41(29.3) | 49(25.5) |  |
 AWSTEMI, n(%) | 39(27.9) | 63(32.8) |  |
 NAWSTEMI, n(%) | 60(42.9) | 80(41.7) |  |
Beta-blocker, n(%) | 109(77.9) | 160(83.3) | 0.209 |
Stain, n(%) | 79(56.4) | 125(65.1) | 0.109 |
Vasopressor, n(%) | 113(80.7) | 150(78.1) | 0.566 |
Revascularization, n(%) | 82(58.6) | 129(67.2) | 0.107 |
Clinicals outcomes | Â | Â | Â |
 Mechanical ventilation time, hours | 103.2 ± 10.1 | 49.5 ± 6.0 | 0.000 |
 CCU time, days | 10.1 ± 0.9 | 6.1 ± 0.5 | 0.000 |
 CCU mortality, n(%) | 41(29.3) | 34(17.7) | 0.013 |
 Hospital mortality, n(%) | 45(32.1) | 37(19.3) | 0.007 |
 28-days mortality, n(%) | 54(38.6) | 43(22.4) | 0.001 |